1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Life Science Laboratory Automation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porters Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Life Science Laboratory Automation Market, by Product/Component
8.1.1. Hardware (liquid handlers, robotic arms, plate readers, storage & incubators)
8.1.1.1. Market Revenue and Forecast
8.1.2. Software (LIMS, ELN, orchestration, analytics, scheduling)
8.1.2.1. Market Revenue and Forecast
8.1.3. Services (integration, validation, maintenance, managed automation)
8.1.3.1. Market Revenue and Forecast
9.1. Life Science Laboratory Automation Market, by Technology/Instrument Type
9.1.1. Liquid-handling & pipetting robots
9.1.1.1. Market Revenue and Forecast
9.1.2. Automated sample prep & nucleic acid extraction systems
9.1.2.1. Market Revenue and Forecast
9.1.3. Plate readers & detection instruments
9.1.3.1. Market Revenue and Forecast
9.1.4. Robotic arms/pick-and-place/mobile robots
9.1.4.1. Market Revenue and Forecast
9.1.5. Automated storage & sample management (freezers, biobanks)
9.1.5.1. Market Revenue and Forecast
10.1. Life Science Laboratory Automation Market, by Application
10.1.1. Drug discovery & high-throughput screening (HTS)
10.1.1.1. Market Revenue and Forecast
10.1.2. Genomics & NGS sample preparation
10.1.2.1. Market Revenue and Forecast
10.1.3. Clinical diagnostics & IVD automation
10.1.3.1. Market Revenue and Forecast
10.1.4. Bioprocess development & QC automation
10.1.4.1. Market Revenue and Forecast
11.1. Life Science Laboratory Automation Market, by End-User
11.1.1. Pharmaceutical & biotechnology companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Clinical & diagnostic laboratories
11.1.2.1. Market Revenue and Forecast
11.1.3. CROs & contract testing labs
11.1.3.1. Market Revenue and Forecast
11.1.4. Analog, MEMS and Others
11.1.4.1. Market Revenue and Forecast
11.1.5. Academic & research institutes
11.1.5.1. Market Revenue and Forecast
12.1. Life Science Laboratory Automation Market, by Deployment/Integration Model
12.1.1. Standalone instruments (bench-top)
12.1.1.1. Market Revenue and Forecast
12.1.2. Integrated/Walk-away automation systems
12.1.2.1. Market Revenue and Forecast
12.1.3. Fully integrated LIMS/ELN + orchestration (on-premise)
12.1.3.1. Market Revenue and Forecast
12.1.4. Cloud-enabled orchestration/remote management (SaaS)
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product/Component
13.1.2. Market Revenue and Forecast, by Technology/Instrument Type
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by End-User
13.1.5. Market Revenue and Forecast, by Deployment/Integration Model
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product/Component
13.1.6.2. Market Revenue and Forecast, by Technology/Instrument Type
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by End-User
13.1.6.5. Market Revenue and Forecast, by Deployment/Integration Model
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product/Component
13.1.7.2. Market Revenue and Forecast, by Technology/Instrument Type
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by End-User
13.1.7.5. Market Revenue and Forecast, by Deployment/Integration Model
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product/Component
13.2.2. Market Revenue and Forecast, by Technology/Instrument Type
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by End-User
13.2.5. Market Revenue and Forecast, by Deployment/Integration Model
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product/Component
13.2.6.2. Market Revenue and Forecast, by Technology/Instrument Type
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by End-User
13.2.8. Market Revenue and Forecast, by Deployment/Integration Model
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product/Component
13.2.9.2. Market Revenue and Forecast, by Technology/Instrument Type
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by End-User
13.2.11. Market Revenue and Forecast, by Deployment/Integration Model
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product/Component
13.2.12.2. Market Revenue and Forecast, by Technology/Instrument Type
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by End-User
13.2.13. Market Revenue and Forecast, by Deployment/Integration Model
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product/Component
13.2.14.2. Market Revenue and Forecast, by Technology/Instrument Type
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by End-User
13.2.15. Market Revenue and Forecast, by Deployment/Integration Model
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product/Component
13.3.2. Market Revenue and Forecast, by Technology/Instrument Type
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by End-User
13.3.5. Market Revenue and Forecast, by Deployment/Integration Model
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product/Component
13.3.6.2. Market Revenue and Forecast, by Technology/Instrument Type
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by End-User
13.3.7. Market Revenue and Forecast, by Deployment/Integration Model
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product/Component
13.3.8.2. Market Revenue and Forecast, by Technology/Instrument Type
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by End-User
13.3.9. Market Revenue and Forecast, by Deployment/Integration Model
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product/Component
13.3.10.2. Market Revenue and Forecast, by Technology/Instrument Type
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by End-User
13.3.10.5. Market Revenue and Forecast, by Deployment/Integration Model
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product/Component
13.3.11.2. Market Revenue and Forecast, by Technology/Instrument Type
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by End-User
13.3.11.5. Market Revenue and Forecast, by Deployment/Integration Model
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product/Component
13.4.2. Market Revenue and Forecast, by Technology/Instrument Type
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by End-User
13.4.5. Market Revenue and Forecast, by Deployment/Integration Model
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product/Component
13.4.6.2. Market Revenue and Forecast, by Technology/Instrument Type
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by End-User
13.4.7. Market Revenue and Forecast, by Deployment/Integration Model
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product/Component
13.4.8.2. Market Revenue and Forecast, by Technology/Instrument Type
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by End-User
13.4.9. Market Revenue and Forecast, by Deployment/Integration Model
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product/Component
13.4.10.2. Market Revenue and Forecast, by Technology/Instrument Type
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by End-User
13.4.10.5. Market Revenue and Forecast, by Deployment/Integration Model
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product/Component
13.4.11.2. Market Revenue and Forecast, by Technology/Instrument Type
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by End-User
13.4.11.5. Market Revenue and Forecast, by Deployment/Integration Model
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product/Component
13.5.2. Market Revenue and Forecast, by Technology/Instrument Type
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by End-User
13.5.5. Market Revenue and Forecast, by Deployment/Integration Model
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product/Component
13.5.6.2. Market Revenue and Forecast, by Technology/Instrument Type
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by End-User
13.5.7. Market Revenue and Forecast, by Deployment/Integration Model
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product/Component
13.5.8.2. Market Revenue and Forecast, by Technology/Instrument Type
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by End-User
13.5.8.5. Market Revenue and Forecast, by Deployment/Integration Model
14.1. Thermo Fisher Scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Danaher Corporation
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Agilent Technologies
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. PerkinElmer
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Tecan Group
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Hamilton Company
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Siemens Healthineer
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Illumina
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. QIAGEN
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abbott
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client